Edition:
United Kingdom

KPC Pharmaceuticals Inc (600422.SS)

600422.SS on Shanghai Stock Exchange

9.48CNY
17 May 2018
Change (% chg)

-- (--)
Prev Close
¥9.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,316,335
52-wk High
¥12.30
52-wk Low
¥7.77

Latest Key Developments (Source: Significant Developments)

KPC Pharmaceuticals says unit to buy stakes in two pharmacy firms for totaling up to 48 mln yuan
Friday, 26 Jan 2018 

Jan 26 (Reuters) - KPC Pharmaceuticals Inc <600422.SS> ::Says its unit plans to use up to 12 million yuan to acquire 60 percent stake in a zhaotong-based pharmacy firm and use up to 36 million yuan to acquire 60 percent stake in a Zhenxiong-based pharmacy firm .  Full Article

BRIEF-KPC Pharmaceuticals Says President Resigns Due To Personal Reasons
Thursday, 28 Dec 2017 

Refiles to remove extraneous 'c' in headline:SAYS PRESIDENT DAI XIAOCHANG RESIGNS DUE TO PERSONAL REASONS.  Full Article

KPC Pharmaceuticals and unit passe review of high-tech enterprise recognition
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - KPC Pharmaceuticals Inc <600422.SS> ::Says it and wholly owned Xishuangbanna medical unit passe review of high-tech enterprise recognition, to enjoy a tax preference of 15 percent for three years .  Full Article

KPC Pharmaceuticals unit to buy 60 pct stake in medical company at 27 mln yuan and invest 6 mln yuan in target company
Friday, 28 Oct 2016 

KPC Pharmaceuticals <600422.SS>: Says its wholly owned subsidiary will buy 60 percent stake in a Qujing-based medical company at 27 million yuan in total .Says the subsidiary will invest 6 million yuan in the target company after acquisition.  Full Article

KPC Pharmaceuticals to buy 60 pct stake in biotechnology co for 25 mln yuan
Monday, 5 Sep 2016 

KPC Pharmaceuticals Inc <600422.SS>:Says it to buy 60 percent stake in a Tibet-based biotechnology co for 25 million yuan.  Full Article

BRIEF-KPC Pharmaceuticals unit to acquire 60 pct stake in pharmaceutical firm for 36.3 mln yuan

* Says co's wholly owned unit plans to acquire 60 percent stake in a pharmaceutical firm, at the price of 36.3 million yuan